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This short review describes application of atom transfer radical polymerization (ATRP) in inverse min-
iemulsion and disulﬁde–thiol exchange to prepare well-deﬁned biodegradable functional nanogels
(ATRP-nanogels). Due to the formation of uniform network, the ATRP-nanogels have higher swelling
ratios, better colloidal stability, and controlled degradation, as compared to nanogels prepared by
conventional free-radical polymerization. Various water-soluble biomolecules such as anticancer drugs,
carbohydrates, proteins, and star branched polymers were incorporated into ATRP-nanogels at high
loading level, by in-situ physical loading or by in-situ chemical incorporation via covalent bonds. The
nanogels crosslinked with disulﬁde or polyester linkages were degraded either in the presence of
biocompatible reducing agents or by hydrolysis for controllable release of the encapsulated drugs. ATRP-
nanogels contain bromine end groups that enable further chain extension and functionalization with
biorelated molecules. They are also easily functionalized by copolymerization with functional monomers
or use of functional ATRP initiator during synthesis. These functional nanogels have capability to be
further chemically modiﬁed and bioconjugated with cell-targeting proteins, antibodies, and integrin-
binding peptides to increase cellular uptake via clathrin-mediated endocytosis. These results suggest that
such well-deﬁned functional nanogels have great potential for targeted drug delivery applications.
 2009 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Polymer-based drug delivery systems (DDS) have attracted signif-
icant attention in biomedicine, pharmaceutics, and bio-nanotech-
nology. In particular, polymer-based DDS with controllable release of
therapeutics and cell targeting have the potential to treat numerous
diseases, including cancers, with a reduction in the side effects of the
drugs. Several types of polymer-based DDS have been explored and
microgels/nanogels are among themost promisingDDS.Microgels are
a class of small crosslinked hydrogel particles. When the microgel
particles are submicron-sized they are known as nanogels. Like
hydrogels, microgels/nanogels are three-dimensional biocompatible
materials with highwater content. In addition, they have tunable size
from submicrons to tens of nanometers, a large surface area for
multivalent bioconjugation, and an interior network for incorporation: þ1 989 638 9425.
: þ1 412 268 6897.
), km3b@andrew.cmu.edu
Y-NC-ND license.of therapeutics [1–3]. Entrapment of biomolecules including anti-
cancer drugs, proteins, carbohydrates, DNA, genes, nucleic acids, and
inorganic nanoparticles in microgels/nanogels as well as their in vitro
release have been already extensively investigated [4–14].
Several criteria, including control over biological, chemical, and
physical properties, are required for the design and development of
effective microgel/nanogel-based DDS for in vivo biomedical appli-
cations. They include non-toxicity to cells, stability for prolonged
circulation in blood stream, high loading efﬁciency and controllable
release of therapeutics, in addition to functionality for further bio-
conjugation, dimensional control, and biodegradability. The last
criterion modulates the release of therapeutics for a desired period
of time aswell as enables the removal of the empty device after drug
release. A common approach to biodegradability is to introduce
(bio)degradable linkages into the microgel/nanogel crosslinked
network. The linkages reported in literature include oligolactate
esters [15–19], anhydrides [20], peptides [21–24], polyperoxides
[25], 1,2-dihydroxyethylenes [26], acetals [27–33], poly(3-hydroxy-
butyrate) [34], polyphosphoesters [35,36], disulﬁdes [4,37], and
hydrazones [38,39]. The resulting crosslinked polymers are
degraded to water-soluble polymers in external environments.
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Fig. 1. Illustration of unique features of biodegradable nanogels prepared by atom transfer radical polymerization in inverse miniemulsion of oligo(ethylene glycol) monomethyl
methacrylate in the presence of a disulﬁde-functionalized dimethacrylate.
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merization of hydrophilic or water-soluble monomers in the pres-
ence of difunctional or multifunctional crosslinkers [4]. They
include photolithographic [40], micromolding [41,42], microﬂuidic
[43,44], reverse micellar [45,46], membrane emulsiﬁcation [47,48],
and homogeneous gelationmethods [49,50]. They are also prepared
by heterogeneous free-radical polymerization in various media
including dispersion [51,52], precipitation [53–55], inverse (mini)-
emulsion, and inverse microemulsion. However, due to the use of
uncontrolled polymerization processes, all of these examples
resulted in the preparation of polymers with broad molecular
weight distribution (i.e. Mw/Mn> 2.0).
Controlled/living radical polymerization (CRP) techniques [56–
61] have been explored in various media including water, (inverse)
miniemulsion, and dispersion for the preparation of crosslinked
particles and gels with well-controlled polymer segments [62–71].
Nevertheless, only a few papers report the use of CRP methods to
prepare well-deﬁned microgels/nanogels. Atom transfer radical
polymerization (ATRP) [72,73] in water yielded poly(N-isopropyl
acrylamide) (PNIPAM)-based nanogels with a diameter 67 nm in
water at 25 C [21]. Reversible addition fragmentation transfer
(RAFT) polymerization allowed for the preparation of acid-cleavable
core-shell nanoparticles [74], poly(vinyl acetate)-based nanogels
[75], thermally-responsive [76] and double hydrophilic [77] block
copolymer nanogels.sonication
Oil layer
Water-soluble species
(monomers, water, and 
initiator)
surfactant
cyclohexane
Aqueous layer
Fig. 2. A schematic representation of inverse miniemulsion or microemulsion polymerizatio
polymers as well as crosslinked particles in the presence of crosslinkers.Recently, a versatile method for preparing and functionalizing
well-deﬁned biodegradable nanogels for targeted drug delivery
applications has been developed [4,78–82]. The method utilizes
ATRP [72,73], inverse miniemulsion polymerization [83], and
disulﬁde–thiol exchange [84,85]. The novel approach allows the
preparation of biomaterials withmany useful predeterminable site-
speciﬁc features. As illustrated in Fig.1, the features include uniform
network, high loading efﬁciency, novel distributed functionality
including bromine end groups, and degradation by hydrolysis or
through a disulﬁde–thiol exchange. This paper will review the
preparation, functionalization, and biomedical applications of well-
deﬁned non-crosslinked and crosslinked nanogels of poly(oligo-
(ethylene glycol) monomethyl ether methacrylate) (POEOMA) by
inverse miniemulsion ATRP.
1.1. Inverse miniemulsion and microemulsion polymerization
Inverse miniemulsion polymerization is a water-in-oil (W/O)
heterogeneous polymerization process that forms kinetically stable
macroemulsions at, below, or around the critical micellar concen-
tration (CMC). This process contains aqueous droplets (including
water-soluble monomers) stably dispersed, with the aid of oil-
soluble surfactants, in a continuous organic medium. Stable inverse
miniemulsions are formedunderhigh shear byeither a homogenizer
or a high speed mechanical stirrer. Oil-soluble nonionic surfactantsoil-soluble 
surfactant
acrylamide inverse
miniemulsion
d = 200 nm
n for the preparation of nanometer-sized particles of water-soluble and water-swellable
Fig. 3. Mechanism of AGET ATRP, where ka, kda, kp, and kt are the rate constants of
activation, deactivation, propagation, and termination, respectively.
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implement colloidal stability of the resulting inverse emulsion. Upon
addition of radical initiators, polymerization occurs within the
aqueous droplets producing colloidal particles (Fig. 2) [83]. Several
reports have demonstrated the preparation of stable particles of
hydrophilic and water-soluble polymers [86–89], polyaniline nano-
particles [90], and organic–inorganic hybrid particles [91–93]. This
method also allows for the preparation of crosslinked microgels in
the presence of difunctional crosslinkers [27,94–100]. In addition,
CRP techniques including ATRP [78,79,82,101,102] and RAFT [103] in
inverse miniemulsion have been explored to prepare well-deﬁned
nanoparticles and nanogels.
Inverse microemulsion polymerization also involves aqueous
droplets, stablydispersedwith the aidof a large amountof oil-soluble
surfactants, above the criticalmicellar concentration, in a continuous
organicmedium. Polymerizationoccurswithin the aqueous droplets,
producing stable hydrophilic water-soluble colloidal nanoparticles
with a diameter of less than 50–100 nm [104,105]. This method has
been also explored for the preparation of well-deﬁned nanoparticles
[106–111], magnetic polymeric particles [112,113], and nanogels in
the presence of difunctional crosslinkers [114–119].
The resulting nanogels by both polymerization methods are
produced in the form of dispersions in organic solvents with oil-
soluble surfactants. Biomedical applications require removal of
residual monomers, oil-soluble surfactants, and organic solvents.
Nanogels are then redispersed in water before use. For comparison,
aqueous precipitationpolymerization ofwater-solublemonomers in
the presence of difunctional crosslinkers is also allowed for the
preparation of microgels/nanogels [4,71,76,120–122]. However, in
order to avoidmicroscopic gelation, the concentration of monomers
in water (reaction media) should be kept low. In addition, this
method also needs the puriﬁcation of the resulting polymers by
removal of residualmonomers and initiators from reactionmixtures.
1.2. Activators generated by electron transfer for ATRP (AGET ATRP)
ATRP is one of the most successful CRP techniques, enabling the
preparation of a wide spectrum of polymers with predetermined
molecular weight and relatively narrow molecular weight distribu-
tion (Mw/Mn< 1.5) [56,59,73,123–126]. ATRP also allows for the
preparation of copolymerswith different chain architectures, such as
block, random, gradient, comb-shaped, brush, and multi-armed star
copolymers [57,58,77,127–134]. In addition, ATRP has been utilized to
prepare polymer–protein/peptide bioconjugates [135–142], polymer-
modiﬁed polysaccharides [143–148], micellar nanoparticulates
[149–155], hydrogels and nanogels [80], ligands stabilizing
metal nanocrystals for cellular imaging [156–159], surface-initi-
ated brushes [70,160–163], and emulsion particles [164–166].
Themechanism of ATRP is based on a rapid dynamic equilibration
between aminute amount of growing radicals and a largemajority of
dormant species [59,123,167–170]. In a normal ATRP process (Fig. 3),
transition metal complexes in a lower oxidation state (Cu(I)/Lm) are
added directly to the reaction as an activator, which reacts reversibly
with thedormant species (RX) to generate a deactivator (X–Cu(II)/Lm)
and an active radical (R). The radical can propagate by addition of
monomers (M), and is rapidly deactivated by reactionwith X–Cu(II)/
Lm, regenerating Cu(I)/Lm and a halogen-terminated polymeric chain.
Activators generated by electron transfer, (AGET) ATRP is a recently
developed initiating process for ATRP with the beneﬁt of addition of
a more stable catalyst complex to the reaction mixture. This process
uses reducing agents, such as tin(II) 2-ethylhexanoate in organic
solventsorascorbicacid inaqueous solutions,which reactwithCu(II)/
Lm catalyst precursors to generate the active Cu(I)/Lm catalysts. The
process then follows normal ATRP. This AGETATRPmethod has been
successfully conducted in various homogeneous media includingbulk [171–174], protic [175], and aqueous solution [176] as well as
heterogeneous media including microemulsion [177], ab initio
emulsion [178], miniemulsion [179–183], dispersion [184], and
inverse miniemulsion [79,81].2. Preparation of non-crosslinked particles by AGET ATRP in
inverse miniemulsion
2.1. Particles of well-controlled water-soluble POEOMA
OEOMA is a water-soluble methacrylate-based macromonomer
with pendent oligo(ethylene oxide) (OEO) chain. Several grades of
OEOMA,with differentOEO chain lengths are commercially available,
including OEOMA300 (M¼ 300 g/mol, pendent EO unitsz 5),
OEOMA475 (M¼ 475 g/mol, pendent EOunitsz 9), andOEOMA1100
(M¼ 1100 g/mol, pendent EO unitsz 23), as shown in Fig. 4. OEOMA
is an analogue of linear poly(ethylene oxide) (PEO), which is
biocompatible and prevent nanoparticle uptake by reticularendo-
thelial system (RES) [185].
Many requirements should be met in order to conduct
a successful ATRP in inverse miniemulsion. One of the requirements
is colloidal stability. This mainly involves the selection of the correct
surfactants to form stable aqueous monomer droplets, and the
resulting polymeric particles, in a continuous oil phase such as
cyclohexane. Span 80 (sorbitan monooleate) formed stable inverse
miniemulsions ofOEOMAwithwater in cyclohexane, resulting in the
formation stable POEOMAparticles. The useofwater as a solventwas
necessary to stabilize aqueous phase as well as a lipophobe to build
up anosmotic pressure in inverseminiemulsion droplets. Optionally,
an addition of highmolecularweight poly(ethylene glycol) (PEG) can
be added as costabilizer to enhance colloidal stability of POEOMA
particles in inverse miniemulsion polymerization.
Other requirements involve selecting suitable conditions for
conducting AGET ATRP in water, since the polymerization occurs in
the aqueous monomer droplets dispersed in an organic media. All
ATRP ingredients including initiator, catalyst, ligand, and reducing
agent should be soluble in water. Various water-soluble, high
molecular weight PEO-functionalized bromoisobutyrate initiators
were synthesized [176], producing PEO-b-POEOMA block copoly-
mers. They include monofunctional PEO113-Br, PEO45-Br, and
bifunctional Br-PEO77-Br (the numbers in subscript indicate the
degree of polymerization of the EO units). Dissociation of Br–Cu(II)
bond, present in the ATRP deactivator, in water could result in
a reduction of the rate of deactivation, leading to a loss of control
[186]. Since tri[(2-pyridyl)methyl]amine (TPMA) is known to
provide an active water-soluble complex with a low tendency for
disproportionation [187], the use of TPMA [186] as the ligand
forming the CuBr2 catalyst precursor complex overcomes such
Fig. 4. Chemical structures of reagents used for AGET ATRP inverse miniemulsion.
J.K. Oh et al. / Polymer 50 (2009) 4407–44234410problems. Water-soluble ascorbic acid (AscA) was typically used as
the reducing agent.
Table 1 summarizes the AGET ATRP of OEOMA in cyclohexane
inverse miniemulsion conducted with various OEOMA monomers
and PEO-based macroinitiators (entries 1–4), targeting DP¼ 600
(entry 5), and block copolymerization (entry 6). All polymerization
produced well-controlled PEO-b-POEOMA and PEO-b-POEOMA300-
b-PEOMA475 copolymers with narrow molecular weight distribu-
tions (Mw/Mn< 1.3). In addition, all polymerization produced nano-
meter-sized particles with narrow and monomodal size distribution.
2.2. Hydroxy-functionalized particles of well-controlled water-
soluble POEOMA
Water-soluble 2-hydroxyethyl 2-bromoisobutyrate (OH-EBiB) has
been utilized for the synthesis of hydroxy-functionalized polymers
[58] and hydroxy-telechelic polymers [188–191]. OH-EBiB was used
as a water-soluble ATRP initiator for AGET ATRP of OEOMA targeting
DP¼ 300 in cyclohexane inverse miniemulsion [102], creating
submicron-sized particles of well-controlled OH-functionalizedTable 1
Detailed experimental conditions, conversion, and molecular weight data of PEO-b-POEO
Entry Monomerb Initiator (I) [M]0/[I]0/[CuBr2/TPMA]0 [AscA]0
c (mol
1 OEOMA300 PEO113-Br 300/1/0.5 90
2 OEOMA300 PEO45-Br 300/1/0.5 90
3 OEOMA475 PEO45-Br 300/1/0.5 70
4 OEOMA1100 PEO113-Br 70/1/0.5 70
5 OEOMA475 PEO113-Br 600/1/1 70
6 OEOMA475 POEOMA300-Br 223/1/0.6 90
7 OEOMA475 OH-EBiB 300/1/0.5 70
8 OEOMA300 OH-EBiB 300/1/0.5 150
9 HEMA PEO113-Br 300/1/0.5 70
a Conditions for inverse miniemulsion AGET ATRP: monomer/water¼ 1/1 v/v; solids c
b Surfactant: Span 80 for OEOMA and PO-b-PEO for HEMA.
c Based on [CuBr2/TPMA]0.
d Mn,th¼MW (I)þMW(monomer) ([monomer]0/[I]0) conversion.
e Calibrated with PMMA standards.POEOMA at the end of chains (entries 7 and 8, Table 1). In both
reactions, conversions reached 75–80%, producing well-controlled
polymers with Mw/Mn< 1.3. The puriﬁed OH-POEOMA was further
functionalized with biotin, RGD tripeptide, and pyrene (a ﬂuorescent
dye) demonstrating the facile functionalization of crosslinked
nanogels with cell-targeting agents for targeted drug delivery
applications [195].
2.3. Particles of well-controlled water-swellable PHEMA
Hydroxyethyl methacrylate (HEMA) is a water-soluble mono-
mer, but PHEMA is water-swellable polymer. A stableminiemulsion
of HEMA was formed when poly(ethylene-co-butylene)-block-
poly(ethylene oxide) (PO-b-PEO) (Mn¼ 8100 g/mol and 41 wt% of
EO) was used as a surfactant for a stable inverse miniemulsion of
HEMA and PHEMA. An AGET ATRP of HEMA targeting DP¼ 300 in
an inverse miniemulsion yielded well-controlled PEO-b-PHEMA
with monomodal GPC curve and lowMw/Mn< 1.3 at 78% monomer
conversion (entry 9, Table 1). A well-controlled PHEMA80-b-PEO77-
b-PHEMA80 triblock copolymer was also prepared in the presenceMA and PEO-b-PHEMA prepared by AGET ATRP in inverse miniemulsion at 30 C.a
%) Conv (%) Mn,th
d (g/mol) Mn,exp
e (g/mol) Mw/Mn
e Diameter (nm)
73 71,200 71,100 1.29 120–150
73 68,200 64,100 1.23 174
88 119,500 127,500 1.35 212
88 73,000 67,200 1.29 185–210
62 182,000 81,000 1.32 143
85 64,100 68,500 1.30 226
80 114,000 72,000 1.25
75 67,500 25,000 1.3
78 35,400 49,400 1.29
ontent¼ 10 wt%.
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Fig. 5. An increase of size of POEOMA300 nanogels prepared by AGET ATRP of
OEOMA300 in cyclohexane inverse miniemulsion in the presence of different amounts
of DMA-PEOSS. Conditions: [OEOMA300]0/[PEO45-Br]0/[CuBr2/TPMA]0/[AscA]0¼ 300/
1/0.5/0.35; OEOMA300/water¼ 1/1 v/v; solids content¼ 10 wt%. The diameter of
nanogels dispersed in cyclohexane was measured by DLS.
Fig. 6. AFM height (a and c) and phase (b and d) images of uncrosslinked (a and b) and cross
by inverse miniemulsion ATRP at 30 C. Each image frame is 10 mm 10 mm. Reprinted wit
J.K. Oh et al. / Polymer 50 (2009) 4407–4423 4411of difunctional Br-PEO77-Brmacroinitiator. PHEMA, with DP¼ 80, is
not soluble in water while PEO is soluble in water. Consequently,
the resulting block copolymers self-assembled to form micellar
nanoparticles consisting of 9 – 10 PHEMA80-b-PEO77-b-PHEMA80
triblock copolymers with a diameter¼ 13 nm in water [81].3. Preparation of nanogels crosslinked with biodegradable
linkages by inverse miniemulsion ATRP
3.1. Nanogels crosslinked with degradable disulﬁde linkages
The synthesis of dithiopropionyl poly(ethylene glycol) dimeth-
acrylate (DMA-PEOSS, Fig. 4), a water-soluble disulﬁde-functional-
ized crosslinker, was reported elsewhere [78]. A series of
biodegradable crosslinkednanogels ofwell-controlled POEOMA300
were prepared by AGET ATRP of OEOMA300 targeting DP¼ 300 in
inverseminiemulsion in the presence of different amounts of DMA-
PEOSS. As shown in Fig. 5, the sizes of crosslinked particles were
larger than those of uncrosslinked particles dispersed in cyclo-
hexane. As the ratio of [DMA-PEOSS]0/[PEO45-Br]0 increased, the
size and size distribution of nanogels increased. For the ratio of
[DMA-PEOSS]0/[PEO45-Br]0> 4/1, the resulting particles did not
dissolve in solvents, including THF and water.
Fig. 6 shows AFM height and phase images of uncrosslinked and
crosslinked POEOMA300 particles on mica surfaces. The particlelinked (c and d) POEOMA300 particles prepared with [DMA-PEOSS]0/[PEO45-Br]0¼ 4/1
h permission from Ref. [78]. Copyright 2006 American Chemical Society.
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Fig. 7. CONTIN plots for RITC-Dex loaded POEOMA300-co-PHEMA nanogels before (a.
Size: 203 nm, CV¼ 0.48) and after acid catalyzed hydrolysis (b. Size: 9 nm, CV¼ 0.44).
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average diameter determined by AFM analysis was 310 nm, i.e.w2
times larger than that determined by DLS (145 nm). The difference
is due to ﬂattening of the particles on the mica surface during the
casting process, as conﬁrmed by their small height (18 nm). For
crosslinked particles prepared with [DMA-PEOSS]0/[PEO45-
Br]0¼ 4/1, the particle size distribution was broader. However, the
difference of particle diameter determined by AFM and DLS
decreased; the ratio of the sizes determined by AFM (425 nm) to
that by DLS (260 nm) was 1.6 times. This is because crosslinked
particles spread out on the mica surface to a lesser degree, as
conﬁrmed by their relatively greater height (55 nm compared to
18 nm) [78].3.2. Nanogels crosslinked with hydrolyzable polyester linkages
Recently, poly(ethylene glycol)-co-poly(glycolic acid) dimeth-
acrylate (PEG-PGADM) was synthesized [192–194] and used as an
hydrolyzable crosslinker for the preparation of biodegradableFig. 8. Two approaches to prepare OH-functionalized biodegradPOEOMA300-co-PHEMA nanogels by AGET ATRP. These nanogels
degraded upon hydrolysis of oligo(a-hydroxy acid)s into water-
soluble polymers, as decreasing the diameter from 203 nm to 9 nm
(Fig. 7). The degraded polymers residues with low molecular
weights can be facilitated for excretion from the body via renal
ﬁltration in an in vivo application.
3.3. OH-functionalized biodegradable nanogels
The preparation of functionalized nanogels is required to allow
bioconjugation of the nanogels for targeted drug delivery applica-
tions. Two approaches were examined for the preparation of OH-
functionalized nanogels crosslinked with disulﬁde and polyester
linkages (Fig. 8). One approach involves an introduction of func-
tional monomers, particularly 2-hydroxyethyl acrylate (HEA,
10 mol% of OEOMA) at certain conversion (ca. 30%) during inverse
miniemulsion ATRP of OEOMA300 in the presence of DMA-PEOSS.
This approach enabled preparation of functional nanogels of PEO-
b-POEOMA-b-P(OEOMA-co-HEA) block copolymers with pendent
OH groups. The average particle size was 225 24 nm for the
homopolymeric nanogels and 236 29 nm for OH-containing
nanogels, indicating an average increase in the size of the OH-
nanogels by 10 nm after the addition of HEA [80]. Similarly, HEMA
(25 mol% of OEOMA) was copolymerized with OEOMA300 in the
presence of PEG-PGADM crosslinker, producing hydrolyzable OH-
functionalized nanogels. The resulting POEOMA300-co-PHEMA
nanogels with a diameter of 20311 nmwere stable in water over
a long period of time (7 days) without any sign of precipitation.
Another approach involves the use of an OH-EBiB initiator for AGET
ATRP of OEOMA300 in cyclohexane inverse miniemulsion in the
presence of DMA-PEOSS. Functional nanogels of PEO-b-PEOMA300
with terminal OH groups were prepared [102].
4. Comparison of nanogels prepared by ATRP with those by
conventional FRP
A conventional free-radical polymerization (FRP) of OEOMA300
in inverse miniemulsion in cyclohexane in the presence of 1.5 mol%
DMA-PEOSS was initiated with 2,2-azobis(4-methoxy-2,4-
dimethyl valeronitrile) (V-70, Wako Chemie) at 40 C, resulting in
the formation of FRP-nanogels. Fig. 9 compares the swelling ratios
of ATRP-nanogels with these FRP-nanogels in different solvents
including THF, toluene, and water. The swelling ratios of the
nanogels were determined by the weight ratio of wet gels to dried
gels. For ATRP gels, the swelling ratios ranged fromw20 in organic
solvents (THF and toluene) tow28 inwater. These values were 1.6–
1.8 times larger than those for FRP gels in all solvents examined.
This difference could be ascribed to crosslinks being more evenly
distributed in ATRP-nanogels. Furthermore, FRP-nanogels were not
degraded in the presence of tributyl phosphine (Bu3P) in THF (seeable nanogels by ATRP of OEOMA in inverse miniemulsion.
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Fig. 9. Comparison of swelling ratio of degradable nanogels prepared by inverse
miniemulsion using ATRP and FRP in various solvents. Both gels were prepared in the
presence of 1.5 mol% DMA-PEOSS. Swelling ratios of nanogels were determined by the
weight ratio of wet gels to dried gels.
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inverseminiemulsion ATRP in the presence of a crosslinker resulted
in the formation of nanogels with a uniform network structure. The
ATRP-nanogels had larger swelling ratios than FRP-nanogels in
various solvents. They could be redispersed in water to form stable
hydrogels with a large swelling ratio of 28.
5. Live/dead cytotoxicity of nanogels and degraded polymers
The cytotoxicity of nanogels and their degradation products in
the presence of glutathione was examined using the LIVE/DEAD
Viability/Cytotoxicity. An aliquot of nanogels and degraded nano-
gels was cultured with HeLa cells. After 24 h incubation, ﬂuores-
cence microscopy was used to visualize live (green ﬂuorescence)
and dead (red ﬂuorescence) cells. Fig. 10 shows the combined
images for live and dead HeLa cells in the presence of nanogels. TheFig. 10. Fluorescent image of live (green) and dead (red) HeLa cells after 24 h incu-
bation with nanogels. The gels were puriﬁed by extensive dialysis in water for 7 days.
Scale bar¼ 200 mm. Reprinted with permission from Ref. [80]. Copyright 2007 Amer-
ican Chemical Society.viability of HeLa cells was 89% in the presence of nanogels an 94% in
the presence of degraded nanogels, compared with 95–96% in the
their absence as a control experiment. These results suggest that
POEOMA nanogels prepared by inverse ATRP miniemulsion, and
the degraded nanogels in the presence of glutathione, are non-toxic
to cells and biocompatible [80].
6. Loading of ﬂuorescent dyes, biomolecules, polymers, and
inorganic nanoparticles into nanogels
Several methods were utilized to incorporate various water-
soluble and dispersible (bio)molecules into the nanogels. They
include incorporation of ﬂuorescent dyes, anticancer drugs, gold
nanoparticles (AuNPs), high molecular weight carbohydrate and
protein drugs, and star branched polymers. Low molecular weight
ﬂuorescent dyes, anticancer drugs, and AuNPs were physically
loaded into puriﬁed nanogels (physical loading), while high
molecular weight biomolecules such as carbohydrates and proteins
were physically incorporated into nanogels during the inverse
miniemulsion ATRP (in-situ physical incorporation). Star branched
polymeric nanoparticles having ATRP bromine initiating moieties
were covalently incorporated into nanogel networks during inverse
miniemulsion ATRP (in-situ covalent incorporation).
6.1. Physical loading of Rhodamine 6G, Doxorubicin, and AuNPs
Nanogels prepared by inverseminiemulsion ATRP in cyclohexane
were ﬁrst puriﬁed by precipitation inTHF, followed by centrifugation
to remove THF-soluble species, including unreacted OEOMA300 and
Span 80 (surfactant). The dried nanogels were fully swollen inwater
and then magnetically stirred with various amounts of Rhodamine
6G (R6G, expressed as the wt ratio of R6G to nanogel in water) for 3
days at room temperature. After the mixtures were transferred into
a dialysis tubes (MWCO¼ 6–8 kDa) in water, an aliquot of outer
water was periodically taken for UV–vis measurements. Using the
pre-constructed calibration curve of R6G and its extinction coefﬁ-
cient (3¼ 80,000 M1 cm1 at l¼ 526 nm) in water, the amount of
freeR6Gdyes removed from themixture throughdialysis tubingwas
determined.
Fig. 11a shows the wt% of accumulated R6G in outer water to
originally added R6G. In a controlled experiment conducted only
with R6G, without nanogels, the wt% reached 100% within 3 days,
indicating complete removal of all R6Gdyes from thedialysis tube. In
all experiments with different weight ratios of R6G/nanogel,
a plateauofwt%wasobservedafter 3 days. Consequently, the loading
level of R6G in the nanogels (i.e. amount of R6G remaining in the
nanogels) was calculated after 3 days. As seen in Fig.11b, the loading
level increased with the wt ratio of R6G/nanogel and reached
a plateau at 34% with wt ratio of R6G/nanogel> 1.5.
Doxorubicin (Dox, called adriamycin or hydroxyldaunorubicin)
is an amphiphilic DNA-interacting drug widely used in chemo-
therapy and has been physically entrapped in hydrogels [96,120]. In
the experiments [96], Dox was also loaded into nanogels in water,
using a similar procedure to that used for R6D loading. The loading
level was determined using the extinction coefﬁcient of Dox
(3¼ 7600 M1 cm1 at l¼ 497 nm) in water. The loading level of
Dox into nanogel increased from 5.4 to 16.4 wt% as the initial ratio
of Dox/nanogel in mixture increased from 0.07/1 to 0.35/1. Such
increase is due to an increase in extent of both hydrophobic and
hydrophilic interactions between Dox and OEO segments, because
they have amphiphilic character. Similar results were observed for
nanogels based on Pluronic F127 containing hydrophobic poly-
(propylene glycol) where the amount of Dox loaded into nanogels
increased from 2.7 to 8.9 wt% as the initial ratio of Dox/nanogel
increased from 0.1/1 to 0.2/1 [96].
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J.K. Oh et al. / Polymer 50 (2009) 4407–44234414Inorganic gold nanoparticles (AuNPs) with a diameter of 2 nm
were incorporated by mixing POEOMA300 nanogels (2.45 mg/mL)
with AuNPs (0.25 mM) in water for 2 days. Unabsorbed AuNPs were
removed by dialysis tubing (MWCO¼ 12–14 kDa) in water. Ther-
mogravimetric analysis suggested that each AuNP-loaded nanogel
contained approximately 3000 AuNPs, corresponding to 42% bymass
or 3.6% by volume [195]. The results are promising for site-speciﬁc
drug delivery and photodynamic therapy (PDT) applications [196].Table 2
Extent of incorporation of RITC-Dex in nanogels prepared by AGET ATRP of
OEOMA300 in cyclohexane inverse miniemulsion in the presence of DMA-PEOSS
and RITC-Dex at 30 C.c
RITC-Dex added to polymerization (wt%) Incorporation
Levela (%) Efﬁciencyb (%)
2.9 4.0 84
6.8 9.1 81
a Weight ratio of RITC-Dex to nanogels.
b Weight ratio of RITC-Dex incorporated into nanogels to that added to poly-
merization. Efﬁciency (%)¼ level/(amount of RITC-Dex added to polymerization/
conversion). The amount of RITC-Dex added to the polymerization was calculated
based on monomer conversion to be 60% determined by GPC measurements.
c Reprinted with permission from Ref. [82]. Copyright 2007 American Chemical
Society.6.2. In-situ physical incorporation of high molecular weight
carbohydrates and proteins
High molecular weight biomolecules such as carbohydrates,
proteins, and DNA as model water-soluble macromolecular drugs
were incorporated into microgels during heterogeneous free-radical
polymerization. A few reports described the preparation of dextran
(Dex)-loaded hydrogels by post-polymerization crosslinking of
poly(N-isopropylacrylamide-co-allylamine) microgels with glutaric
dialdehyde in the presence of Texas Red-labeled dextran [197],
crosslinked poly(vinyl pyrrolidone) nanoparticles in the presence of
ﬂuorescein isothiocyanate-labeled dextran using a reverse micellar
technique [115,116], and polyacrylamidemicrogels in the presence of
ovalbumin and plasmid DNA by inverse miniemulsion polymeriza-
tion [99,100].
Biodegradable POEOMA nanogels loaded with rhodamine iso-
thiocyanate-labeled dextran (RITC-Dex) were prepared by inverse
miniemulsion ATRP in the presence of 1.5 mol% DMA-PEOSS.
Different amounts of water-soluble RITC-Dex (2.9, 6.8, and 8.2 wt%)
were introduced into the aqueous solution stably dispersed in an
organic continuous phase, resulting in the formation of pink-
colored dispersions of crosslinked RITC-Dex-containing POEOMA
nanogels. The particle size of nanogels prepared in the presence of
up to 6.8 wt% RITC-Dex was ca. 245–250 nm in diameter. The
resulting RITC-Dex-loaded nanogels biodegraded in the presence of
reducing agents (the detailed reductive degradation will be
described in the following section). This degradability allowed use
of UV–vis spectroscopy to determine the degree of incorporation of
RITC-Dex into the nanogels. A linear calibration curve of the
absorbance at 555 nm vs. amount of RITC-Dex was constructed
from UV–vis spectra of various amounts of RITC-Dex in water. A
known amount of the puriﬁed dried RITC-Dex-containing nanogels
was mixed with glutathione (15 wt% of nanogels) in water at room
temperature for 1 day, resulting in the formation of a transparent
pink solution upon degradation of the nanogel. The UV–vis spectraof the solutions were measured. The amount of RITC-Dex loaded in
nanogels was calculated from the absorbance at the wavelength
and the calibration curve (Table 2). The extent and efﬁciency of
incorporation of RITC-Dex in nanogels prepared in the presence of
2.9 wt% RITC-Dex, was 2.4 wt% and 84 wt%, respectively. When the
amount of RITC-Dex was increased from 2.9 to 6.8 wt%, the extent
of incorporation was 5.5 wt%, resulting in slight decrease in efﬁ-
ciency to 81% [82].
Nanogels prepared with HO-EBiB as an ATRP initiator were
utilized to load bovine serum albumin (BSA) into OH-functionalized
nanogels. The resulting nanogels had a diameter of 132 nm with
narrow size distribution by DLS (Fig. 12a). A slightly smaller size
was observed by transmission electron microcopy (TEM) (Fig. 12b).
The resulting crosslinked BSA-containing OH-POEOMA nanogels
were biodegraded into the corresponding thiol-containing poly-
mers, releasing BSA in a controlled manner.
6.3. In-situ covalent incorporation of bromine-functionalized star
branched nanoparticles
Well-deﬁned biodegradable star branched polymeric nano-
particles were prepared by ATRP of a disulﬁde-functionalized
dimethacrylate in the presence of PEO113-Br as a macroinitiator in
MeOH. They consist of a hydrophobic biodegradable crosslinked
core and w20 hydrophilic PEO arms with Mn¼ 10,000 g/mol. The
average diameter of the star copolymers measured by DLS was 20–
30 nm in MeOH. Fig. 13b shows the GPC traces of star branched
polymer before and after degradation. The GPC traces of the star
polymer consist of two peaks; a sharp peak for unreacted PEO113-Br
10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
d = 132 ± 8 nm
L
S
 
I
n
t
e
n
s
i
t
y
Diameter (nm) by DLS
a b
Fig. 12. A CONTIN plot (a) and TEM image (b) of BSA-loaded POEOMA nanogels prepared by AGET ATRP in inverse miniemulsion at 30 C. Conditions: [OEOMA300]0/[HO-EBIB]0/
[DMA-PEOSS]0/[CuBr2/TPMA]0/[AscA]0¼150/1/4//0.5/0.5/0.55, OEOMA300/water¼ 1/1.2 v/v, BSA¼ 25 wt% of OEOMA300. The scale bar¼ 100 nm in (b). Reprinted with permission
form Ref. [195]. Copyright 2009 American Chemical Society.
J.K. Oh et al. / Polymer 50 (2009) 4407–4423 4415with Mnz 10,000 g/mol and a broader peak for high molecular
weight star polymers. These polymers degraded into the corre-
sponding thiol-containing polymers in the presence of tri-
(n-butyl)phosphine (Bu3P) in THF. Since star branched polymers
preserve bromine functionality on the surface of particles, they
were used as macroinitiators for further ATRP polymerization to
prepare mikto-arm star polymers (or star-grafted polymers) [202].
The preparation of mikto-arm star polymers was carried out in
cyclohexane inverse miniemulsion using AGET ATRP of OEOMA300
targeting DP¼ 300. Different amounts of bromine-functionalized
star branched polymers (8.6 and 13.4% of OEOMA300) were added
to the reactions and all polymerizations produced stable nano-
meter-sized particles of POEOMA300 covalently embedded with
star polymers. The particle diameter measured by DLS was 157 nm
for nanogels prepared in the presence of 8.7% star polymer and
230 nm with 13.4% star polymer. Fig. 13a shows that ﬁrst-order
kinetic plots for the polymerizations were linear and that the rate of
polymerization was faster in the presence of 13.4% of the star
branched polymers than with 8.6%. The GPC trace of the star-
grafted POEOMA300 before degradation consisted of two peaks;
a smaller sharp peak with Mnz 10,000 g/mol and a broader peak
for high molecular weight polymers (Fig. 13b). The height of
the former was smaller than that of star branched polymer, while
the latter shifted to high molecular weight. This suggests that the
resulting nanogels consisted of two types of polymers; PEO113-b-0 10 20 30 40 50 60 70 80
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Fig. 13. First-order kinetic plots for AGET ATRP of OEOMA300 targeting DP¼ 300 in inverse
polymeric nanoparticles (a) and GPC traces of degradable star branched polymer and star-gPEOMA300 initiated from unreacted PEO113-Br and POEOMA300
grafted with star branched polymer (star-grafted POEOMA300)
initiated from star branched polymer. The resulting star-grafted
POEOMA300 degraded into corresponding thiol-containing
POEOMA300 in the presence of Bu3P in THF.
A biodegradable POEOMA300 nanogel covalently embedded
with biodegradable star branched polymeric nanoparticles was
prepared by AGET ATRP in inverse miniemulsion in the presence of
1.35% DMA-PEOSS and 13.4% star branched polymers. The average
number of star nanoparticles embedded in a POEOMA300 particle
was estimated to be 55, assuming that the density of star polymer
and POEOMA¼ 1 and the diameter¼ 30 nm for star nanoparticles.
The loading efﬁciency of hydrophobic drugs into the hydrophobic
nanodomain-containing POEOMA nanogels was examined; Pyrene
methanol (Py) was selected as a model hydrophobic drug (48 mg)
and was mixed with the dried nanogels (0.153 g) in THF for 2 days.
The resulting Py-loaded nanogels were isolated and then degraded
in the presence of Bu3P in THF. Using the extinction coefﬁcient of Py
(3¼ 40,000 M1 cm1 in THF), the loading level of Py into hydro-
phobic nanodomain-containing nanogels was calculated to be
9.1 wt%, which is twice larger than that (4.9 wt%) for nanogels
formed without incorporation of hydrophobic star polymers. These
results indicate that the hydrophobic star nanodomains enhanced
loading level of hydrophobic or amphiphilic drugs into hydrophilic
POEOMA nanogels.1000 10000 100000 1000000 1E7
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miniemulsion in the presence of different amounts of Br-functionalized star branched
rafted POEOMA300 before and after degradation in the presence of Bu3P in THF (b).
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Fig. 15. Evolution of weight fraction of remaining nanogels over time in the presence
of different amounts of glutathione, expressed as wt ratio of glutathione/nanogels.
Reprinted with permission from Ref. [80]. Copyright 2007 American Chemical Society.
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reducing agents
Disulﬁde–thiol chemistry has been widely utilized in
conventional polymer syntheses. Disulﬁdes are cleaved to the
corresponding thiols under reducing conditions or through
disulﬁde–thiol exchange. Recent reports describe the use of this
chemistry to design well-deﬁned degradable polymers [84,198–
201], hydrogels [37,202], polymer capsules [203], and micellar
particles [204–209]. Therefore, the reductive degradation of
crosslinked ATRP-nanogels with disulﬁde linkages into the cor-
responding thiol-containing POEOMA300 fragments was inves-
tigated with various reducing agents, including Bu3P, glutathione,
and dithioerythritol (DTT) (Fig. 14).
The reductive degradationwas initially conducted in thepresence
of Bu3P in THF. A known amount of dried nanogels was mixed with
a trace amount of Bu3P inTHFandmagnetically stirred for 3 days. The
degraded polymers were soluble in THF and were characterized
using gel permeation chromatography (GPC), Mn¼ 74,000 g/mol
andMw/Mn¼ 1.5 [78]. However, since Bu3P is hydrophobic and toxic
to cell, the use of hydrophilic or water-soluble reducing agents to
degrade nanogels in vitrowas examined.
Glutathione is a biocompatible tripeptide found within cells at
millimolar concentrations [206,210]. A few reports describe the use
of glutathione as a water-soluble reducing agent that can degrade
disulﬁde-containing polymers to the corresponding thiols [205,206].
The extent of degradation of the nanogel was determined by the
weight loss of swollen nanogels in the presence of different amounts
of glutathione in water over time [80].
Fig. 15 shows the results of degradation. In the absence of
glutathione, the weight fraction of nanogels was almost 100%,
indicating no signiﬁcant degradation. However, in the presence of
glutathione, the weight fraction of nanogels decreased over time,
conﬁrming successful degradation. The degradation rate of nano-
gels increased with the amount of glutathione.Within 1 h, over 85%
nanogels were degraded in the presence of ca. 20 wt% of gluta-
thione (vs. nanogels), while 40% nanogels were degraded in the
presence of 10 wt% of glutathione. Thus, nanogels crosslinked with
disulﬁde linkages were successfully degraded in the presence of
biocompatible reducing agents such as glutathione into the corre-
sponding thiol-containing polymers.8. Controlled release of encapsulated molecules from
nanogels upon degradation
This section describes controllable release of encapsulated
molecules, including ﬂuorescent dyes and anticancer drugs, upon
degradation of nanogels in the presence of glutathione.Fig. 14. Schematic representation of reductive degradation of crosslinked ATRP-
nanogels into corresponding thiol-containing POEOMA segments in the presence of
various reducing agents.8.1. In vitro release of R6G in cellular media
The preparation of POEOMA nanogels loaded with 34% R6G by
the physical loadingmethodwas described in the Section 6.1.When
compared to the Optical Fluorescence Microscopy (OFM) image of
nanogels without ﬂuorescent dyes (Fig. 16a), the distinct bright
spots on the dark background indicate that dyes were localized in
the nanogel particles (b). In contrast, a diffuse ﬂuorescent signals in
the background points out the release of dyes from the nanogels
upon addition of glutathione inwater (c). These results conﬁrm that
degradation of the nanogels could trigger the controllable release of
encapsulated drugs in a reducing environment [80].
In vitro release of R6G from R6G-loaded nanogels upon degra-
dation was demonstrated in cellular environments. Before the
addition of glutathione to a mixture of C2C12 cells incubated with
R6G-loaded nanogels, the red ﬂuorescence was localized in the
large R6G-loaded nanogels (Fig. 17a). When glutathione was added,
nanogels were degraded releasing the R6G dye, which entered and
stained the cells, as shown in Fig. 17b [80].
8.2. In vitro release of Dox to kill HeLa cells
The preparation of POEOMA300 nanogels loaded with 16.4%
Doxwas described in Section 6.1. HeLa cancer cells were incubated
with and without 16.4% Dox-loaded nanogels. After 48 h, the cell
viability was measured using live/dead staining to estimate the
cytotoxicity of the Dox-loaded nanogel before addition of the
reducing agent. After performing this analysis, glutathione was
added to the wells containing the nanogels and free Dox was
added to some of control wells without nanogels. The resulting
mixtures were maintained for another 24 h. As seen in Fig. 18,
before addition of glutathione, the viability of HeLa cells in the
presence of Dox-loaded nanogels was similar to the control. This
suggests that most Dox remained in the nanogels without any
signiﬁcant level of non-speciﬁc leaching of Dox from the nanogels.
This minimization of non-speciﬁc release of drugs during circu-
lation in the blood is important for in vivo application of the
nanogels as drug delivery carriers. Upon addition of glutathione,
the nanogels were degraded and released Dox to kill HeLa cells.
From an analysis based on live/dead cytotoxicity assays after Dox
release, the cell viability was ca. 52% in the presence of Dox-loaded
nanogels, which is lower than that for the control (93%) but
Fig. 16. OFM images of nanogels loaded without (a) and with (b) R6G ﬂuorescent dyes before and (c) after degradation in the presence of glutathione in water. Thin ﬁlms were spin-
cast on a cleaned glass plate and dried at room temperature for 10 min. All scale bars¼ 10 mm. Reprinted with permission from Ref. [80]. Copyright 2007 American Chemical Society.
J.K. Oh et al. / Polymer 50 (2009) 4407–4423 4417around 7 times higher than that in the presence of free Dox (7%).
However, the level of viability is similar in both cases, since the
amount of free Dox added to the wells was 6–7 times larger than
the amount of Dox in the Dox-loaded nanogels. This experiment
demonstrated that the Dox-loaded nanogels are essentially non-
toxic before addition of the reducing agent (48 h mark in the
graph), but after the reducing agent is added, the drug is released,
and the cell growth is signiﬁcantly inhibited due to the presence of
released Dox (72 h mark) [80].
8.3. Release of RITC-Dex for speciﬁc binding to lectins
The preparation of RITC-Dex-loaded nanogels was described in
Section 6.2. RITC-Dex released from nanogels upon degradation inFig. 17. Differential interference contrast (DIC) (left) and ﬂuorescent (right) images of C2C
incubation with R6G-loaded nanogels in the presence of glutathione (b). The red ﬂuorescenc
scale bars¼ 200 mm. All scale bars¼ 10 mm. Reprinted with permission from Ref. [80]. Copya reducing environment could bind to speciﬁc bio-targets such as
lectins. ConA is a well known protein that simultaneously binds to
glucose (homotetramer) at neutral pH [211–214].
A known amount of RITC-Dex-loaded nanogels was degraded in
the presence of glutathione in PBS buffer for 1 day. FT-IR was used
to measure the % transmittance (T%) at 700 nm of the resulting
transparent solution and was determined to be 93%. An aliquot of
ConA solutionwas then added to the transparent solution at weight
ratio of ConA/RITC-Dex¼ 7.0. The transmittance at 700 nm for the
solution was monitored as a function of time. The results could be
compared with those obtained with free RITC-Dex and ConA under
similar conditions (Fig. 19). For both systems, the % transmittance
decreased with time and reached a plateau after 2 days. These
results suggest the formation of aggregates by interacting RITC-Dex12 cells, after 24 h incubation with R6G-loaded nanogels (a), and after another 24 h
e originates from R6G loaded (right in a) to and released (right in b) from nanogels. All
right 2007 American Chemical Society.
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Fig. 18. Viability of HeLa cells after incubation for 48 and 72 h in different systems: (a)
control; (b) Dox-loaded nanogels, where glutathione was added after 48 h incubation
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Fig. 19. Transmittance at 700 nm vs. time for a mixture of RITC-dextran released from
nanogels upon degradation in the presence of glutathione, compared with that of free
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Fig. 20. An illustration of ATRP chain extension with polystyrene from ATRP-nanogels, de
J.K. Oh et al. / Polymer 50 (2009) 4407–44234418molecules with ConA, resulting in an increase in the turbidity of the
mixtures. Large aggregates were ﬁnally precipitated, as observed in
the inset of Fig. 19. These results clearly imply that carbohydrate
drugs released from nanogels upon degradation interact with the
targeted proteins.9. Chain extension, bioconjugation, and cellular uptake of
nanogels
9.1. ATRP chain extension with polystyrene
An advantage of using ATRP is the preservation of halogen chain
end functionality in the resulting polymers. This halide function-
ality enables further chain extension and/or modiﬁcation and
functionalization of the polymers with biorelated molecules. This
section describes ATRP chain extension (ce) of nanogel macro-
initiators with polystyrene as well as degradation of nanogel-ce-PS
and micellization of amphiphilic degraded POEOMA-b-PS in water
(Fig. 20) [78].
The chain extension of ATRP-nanogel macroinitiators with
polystyrene displayed ﬁrst-order kinetics and conversion reached
30% after 19 h. The ﬁnal copolymer was degraded in the presence
of Bu3P in THF for HPLC analysis. As seen in Fig. 21a, there is no
signiﬁcant amount of POEOMA300 macroinitiators left in the
reaction mixture, indicating that most POEOMA300 chains were
functionalized with a bromine end group and capable of chain
extension. The degraded POEOMA300-b-PS block copolymers
self-assembled to form stable uniform spherical micellar parti-
cles consisting of a PS core and POEOMA300 corona.
Fig. 21b. No aggregates were observed. The particle size was
226 48 nm in diameter, as measured by TEM, as compared with
445 30 nm by DLS. These results conﬁrm the successful chain
extension of PS from the active Br-functionality in the POEOMA300
nanogels.9.2. Bioconjugation of nanogels
The preparation of OH-functionalized POEOMA nanogels by
using a functionalized ATRP initiator or introducing HEA or HEMA
during an active inverse miniemulsion ATRP of OEOMA was
described in Section 4. The resulting OH-functionalized nanogels
were reactedwith biotin (Vitamin H) using a carbodiimide coupling
reaction, resulting in the formation of biotin-functionalized nano-
gels [80]. Avidin/2-(4-hydroxyphenylazo)benzoic acid (HABA)
binding assay and OFM was used to evaluate the bioavailability of
biotin present in the nanogels to its protein receptor. Fig. 22a shows
the results from avidin/HABA binding assay. The addition of biotin-
functionalized nanogels to an avidin/HABA solution resulted in
a sharp decrease in the absorbance at 500 nm from 0.79 to 0.27,gradation of nanogel-ce-PS, and micellization of amphiphilic POEOMA-b-PS in water.
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Fig. 21. HPLC chromatograms of POEOMA300 macroinitiator (MI) and POEOMA300-block-PS (a), and TEM image of spherical micelles consisting of PS core and POEOMA300 corona
formed from self-assembly of degraded POEOMA300-block-PS in water (b). Conditions for chain extension of POEOMA300 nanogel macroinitiators with PS in anisole at 90 C:
[styrene]0/[CuBr]0/[PMDETA]0¼ 1605/1/1 and styrene/anisole¼ 50/50 v/v. Reprinted with permission from Ref. [78]. Copyright 2006 American Chemical Society.
J.K. Oh et al. / Polymer 50 (2009) 4407–4423 4419indicating that the biotin molecules in the nanogels competitively
bind to avidin, and replace HABA molecules. Using the calibration
plot determined for free biotin in water [215], the amount of biotin
in the nanogels was calculated to be 16.7 nmol/mg polymer, cor-
responding to 142,000 biotin molecules available in each nanogel
particle, based on the diameter of nanogels in water (310 nm).
The biotin-functionalized nanogels weremixed with ﬂuorescein
isothiocyanate-labeled avidin (FITC–avidin) in PBS buffer for OFM
analysis, resulting in the formation of aggregates of avidin–biotin-
nanogels. As shown in Fig. 22b, the presence of distinct bright spots
on the dark background indicate the formation of complex of
biotin-nanogels with FITC-labeled avidin. The large ﬂuorescent
spots may indicate the formation of large aggregates since each
avidin has four binding pockets to biotin. Formation of similar
aggregates of avidin and biotin-functionalized polymers was also
found in literature [215–217].
Nanogels were also functionalized with oligopeptides, in
particular amino-terminated glycine-arginine-glycine aspartic
acid-serine (GRGDS-NH2), a short ﬁbronectin peptide known to
promote integrin-mediated cell adhesion. For this, OH groups in
POEOMA nanogels were converted to the corresponding carboxylic
acids in a high yield by reacting with succinic anhydride in DMF.
HOOC-POEOMA nanogels were subsequently conjugated withWavelength (nm)
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Fig. 22. UV spectra of HABA and avidin–HABA complex before and after addition of biotin-n
Scale bar¼ 5 mm. Reprinted with permission from Ref. [80]. Copyright 2007 American ChemGRGDS-NH2 via carbodiimide-mediated reaction, producing
GRGDS-conjugated POEOMA nanogels, conﬁrmed by 1H NMR
spectroscopy [102].
9.3. Cellular internalization of nanogels
Cell internalization is one of the key steps for effective delivery
and controllable release of encapsulated molecules. MC3T3-E1
(subclone 4) mouse calvarial osteoprogenitor cells were cultured in
the presence of pure and GRGDS-containing FITC-Dex loaded
POEOMA nanogels. The biocompatible POEOMA nanosized gels
entered cells via clathrin-mediated endocytosis [218]. Flow cytom-
etry was used to quantify cellular uptake of FITC-Dex loaded nano-
gels at different incubation time. Fig. 23 presents count vs. intensity
plots and an illustration of the uniform network of bioconjugated
nanogels with cell-adhesive GRGDS oligopeptide. The internaliza-
tion of pure FITC-Dex loaded nanogels was 62% after 45 min of
incubation and reached up to 82% after 90 min (a). Using similar
experimental conditions, cellular uptake of GRGDS-conjugated FITC-
Dex loaded POEOMA nanogels increased to 95% after 45 min and
nearly complete internalization was obtained after 90 min, with
a shift toward higher ﬂuorescence intensity (b). Bioactive molecules
may promote cell-nanogels interactions leading to efﬁcient cellular0
b
anogels in PBS buffer (a) and OFM image of FITC–avidin–biotin-nanogel conjugates (b).
ical Society.
Fig. 23. Flow cytometry results illustrating ﬂuorescence intensity for FITC-Dextran-loaded POEOMA nanogels with (b) and without (a) bioconjugation of GRGDS. Encapsulation of
FITC-Dextran molecules inside of the uniform peptide-modiﬁed POEOMA network (grey bars) is illustrated (c). [195] (Reprinted with permission from Ref. [195]. Copyright 2009
American Chemical Society).
J.K. Oh et al. / Polymer 50 (2009) 4407–44234420uptake. These results conﬁrmed that nanogels prepared by ATRP in
inverse miniemulsion are endocytosed in cells and are applicable as
drug delivery devices.
10. Fabrication of nanogels for advanced DDS
The development of hybrid polymeric scaffolds with nanosized
materials has offered precise control over the release of biomole-
cules [219]. Novel nanostructured hybrid drug delivery scaffolds
were prepared by a combination of ATRP and conventional free-
radical polymerization (FRP). OH-functionalized nanogels prepared
by AGET ATRP in inverse miniemulsion were ﬁrst modiﬁed with
polymerizable methacrylate groups using two approaches. One
approach involves the reaction of OH groups with methacrylate
anhydride. The other approach involves the reaction of OH groups
with dithiopropionic acid using a coupling chemistry, followed by
reaction with HEMA, yielding HEMA-disulﬁde-functionalized
nanogels. The resulting polymerizable nanogels functionalizedwith
disulﬁde-HEMA were photo-copolymerized with methacrylatedFig. 24. Injectable nanostructured DDS prepared by a combination of ATRP and Michael ad
a biodegradable chemical network under physiological conditions. The nanostructured DDS
components.hyaluronic acid macromonomer, producing biodegradable 3D
hydrogels, in which nanogels were covalently incorporated. Upon
degradation, the disulﬁdes were cleaved to release nanogels from
hydrogels. These novel hybrid polymeric scaffolds are very prom-
ising for tissue engineering applications. They enable control over
release of sequential encapsulated biomolecules from nanogels
such as multiple growth factors, which is required at distinct stages
in the development of important regenerative processes in biology
and medicine [219].
Recently, injectable biomaterials have been the important
subject of much research in both ﬁelds of drug delivery and tissue
engineering, largely due to the minimally invasive nature with
which they can be delivered. A novel in-situ nanostructured poly-
meric 3D DDS was developed by mixing biodegradable thiolated
hyaluronic acid (HA-SH) with hydrolyzable acrylated-POEOMA-co-
PHEMA nanogels (ACRL-nanogels) prepared by AGET ATRP. As
shown in Fig. 24, gelation was achieved via a Michael addition
reaction, leading to a chemically crosslinked hybrid scaffold under
physiological conditions (pH¼ 7.4, 37 C). This novel injectabledition reaction. Employing both water-soluble thiolated HA and ACRLnanogels formed
is resorbable through hydrolysis and enzymatic degradation resulting in water-soluble
J.K. Oh et al. / Polymer 50 (2009) 4407–4423 4421biodegradable scaffold is useful in both tissue engineering and drug
delivery applications. In addition, this approach offers an additional
unique advantage for the mechanism of scaffold degradation.
In vivo applications, matrix resorption can occur via two indepen-
dent pathways; hydrolytic (nanogels) and enzymatic (hyaluronic
acid backbone).
11. Summary and outlook
A versatile method combining ATRP, inverse miniemulsion
polymerization, and disulﬁde–thiol exchange enabled preparation
and functionalization of well-deﬁned biodegradable nanogels with
some useful features for targeted drug delivery applications. In the
absence of the difunctional crosslinker, well-controlled water-
soluble and hydrophilic homo and block copolymers with low
polydispersity (Mw/Mn< 1.3) were produced as stable submicron-
sized particles with diameter from 100 to 300 nm and narrow size
distribution. In the presence of a disulﬁde- or polyester-function-
alized crosslinker, crosslinked biodegradable nanogels were
prepared. They were non-toxic when exposed to cells.
Several methods were explored for loading various water-
soluble biomolecules and inorganic nanoparticles into the nanogels
at high loading levels and high yield. Fluorescent dyes, AuNPs, and
anticancer drugs were incorporated by physical loading, high
molecular weight carbohydrates and proteins by in-situ physical
incorporation, and star branched polymeric nanoparticles by in-situ
covalent incorporation. The nanogels crosslinked with polyester or
disulﬁde linkages were biodegraded either in aqueous media or in
the presence of biocompatible reducing agents such as glutathione,
naturally present within cells. Upon degradation, encapsulated
anticancer drugs such as Dox were released in a controlled manner
to kill cancer cells. Carbohydrate drugs released fromnanogelswere
bound to lectin such as ConA. The nanogels preserved bromine
chain end functionality that enabled further chain extension and
modiﬁcation and functionalization of the nanogels with biorelated
molecules. Functional nanogels were prepared by copolymerization
with functional monomers or through the use of functional ATRP
initiators. They were further functionalized with biorelated mole-
cules, such as cell-adhesive peptides, targeting proteins and anti-
bodies, resulting in the formation of nanogel bioconjugates. Finally,
ATRP-nanogels had higher swelling ratios, better colloidal stability,
and more controlled degradation than FRP-nanogels. These overall
results suggest that well-deﬁned functional nanogels may have
potential as carriers for controlled drug delivery scaffolds to target
speciﬁc cells.
Future design and development of effective microgel/nanogel-
based DDS utilizing CRP methods (not only ATRP) for in vivo appli-
cations to target cancer cells require a higher degree of control over
properties. Targeteddimensions are in the range of 100 nmdiameter,
with a rapid environmental response for enhanced loading level,
novel functionality for further bioconjugation, and biodegradability
for sustained release of drugs. CRP in inverse microemulsion poly-
merization could produce nanogels with diameter less than 50 nm
and with a uniform crosslinked network for better swelling.
Appropriate selection of environmentally responsive water-soluble
andwater-swellable monomers will enable developing biomaterials
responsive to external stimuli. In addition, introductionof acid-labile
degradation linkages with/or without disulﬁde linkages will allow
DDS to be effectively degraded in targeted cancer cells.
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